2019
|
Invention
|
Srm/mrm assays for notch pathway proteins. Methods are provided for detecting and quantifying the... |
|
Invention
|
Srm/mrm assays for notch pathway proteins.
Methods are provided for detecting and quantifying th... |
|
Invention
|
Liquid tissue preparation from histopathological processed biological samples, tissues and cells.... |
|
Invention
|
Srm/mrm assay for the tyrosine-protein kinase receptor ufo(axl) protein. The current disclosure p... |
2018
|
Invention
|
Multiplex mrm assay for evaluation of cancer. The current disclosure provides specific peptides, ... |
|
Invention
|
Predicting cancer treatment outcome with t-dm1.
Improved methods for treating lung cancer are pr... |
|
Invention
|
Predicting gastric cancer treatment outcome. Methods are provided for identifying whether a cance... |
|
Invention
|
Predicting cancer treatment outcome with t-dm1. Improved methods for treating lung cancer are pro... |
|
Invention
|
Immune profiling of tumor tissue.
SRM/MRM assays are used to detect and quantitate proteins invo... |
|
Invention
|
Immune profiling of tumor tissue. SRM/MRM assays are used to detect and quantitate proteins invol... |
|
Invention
|
Quantifying mgmt protein for optimal cancer therapy.
Methods are provided for identifying whethe... |
|
Invention
|
Quantifying mgmt protein for optimal cancer therapy. Methods are provided for identifying whether... |
2017
|
Invention
|
Srm assay to indicate cancer therapy.
The current disclosure provides for specific peptides, and... |
|
Invention
|
Methods of treating cancer by identification of patients sensitive to fgfr inhibitor therapy.
Me... |
|
Invention
|
Improved methods of treating cancer by identification of patients sensitive to fgfr inhibitor the... |
|
Invention
|
Improved methods of treating lung cancer using multiplex proteomic analysis.
The present inventi... |
|
Invention
|
Improved methods of treating lung cancer using multiplex proteomic analysis. The present inventio... |
|
Invention
|
Srm/mrm assays for cd56 and chga proteins.
Methods are provided for quantifying CD56 and CHGA pr... |
|
Invention
|
Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination ther... |
|
Invention
|
Improved methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combina... |
|
Invention
|
Srm/mrm assays for cd56 and chga proteins. Methods are provided for quantifying CD56 and CHGA pro... |
|
Invention
|
Srm/mrm assays for cancer. Methods are provided for quantifying specific proteins directly in bio... |
|
Invention
|
Signal directed dissection to inform cancer therapy strategy.
A novel signal directed tissue mic... |
|
Invention
|
Truncated her2 srm/mrm assay. This disclosure provides ten (10) specific peptides, and particular... |
|
Invention
|
Srm/mrm assay for the tubulin beta-3 chain (tubb3) protein.
The current disclosure provides for ... |
|
Invention
|
Srm/mrm assay for the tubulin beta-3 chain (tubb3) protein. The current disclosure provides for a... |
|
Invention
|
Secreted protein acidic and rich in cysteine (sparc) protein srm/mrm assay.
The current disclosu... |
|
Invention
|
Detection of exon 14 deletion in the met protein. The current disclosure provides for specific pe... |
|
Invention
|
Detection of exon 14 deletion in the met protein. |
|
Invention
|
Method for improved hepatocellular cancer diagnosis.
Methods are provided for determining the di... |
|
Invention
|
Method for improved hepatocellular cancer diagnosis. Methods are provided for determining the dia... |
|
Invention
|
Epidermal growth factor receptor (egfr) protein srm assay.
The current disclosure provides for s... |
|
Invention
|
Quantifying kras for optimal cancer therapy.
Methods are provided for identifying whether a tumo... |
|
Invention
|
Quantifying kras for optimal cancer therapy. Methods are provided for identifying whether a tumor... |
|
Invention
|
Srm/mrm assay for the tumor necrosis factor receptor superfamily member 8 (cd30) protein.
The cu... |
|
Invention
|
Srm/mrm assay for the serine/threonine-protein kinase b-raf (braf).
The current disclosure provi... |
|
Invention
|
Srm/mrm assay for the gtpase kras protein (kras).
The current disclosure provides for specific p... |
|
Invention
|
Quantifying protein for optimal cancer therapy. Methods are provided for identifying whether a lu... |
2016
|
Invention
|
Srm/mrm assays.
Methods are provided for quantifying specific proteins directly in biological sa... |
|
Invention
|
Srm/mrm assays. Methods are provided for quantifying specific proteins directly in biological sam... |
|
Invention
|
Methods for treating her2-positive breast cancer. Methods of treating breast cancer are provided ... |
|
Invention
|
Improved methods for treating her2-positive breast cancer. Methods of treating breast cancer are ... |
|
Invention
|
Quantifying met protein for cancer treatment. Methods are provided for treating a gastric cancer ... |
2015
|
Invention
|
Srm assays to chemotherapy targets.
Methods are provided for quantifying the ENT1, ERCC1, FOLR1,... |
2008
|
G/S
|
Microscope slides; microscope slide covers; [ microscope slide boxes; ] microscope slides for mic... |